Davis Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12K Hold
13
– – ﹤0.01% 490
2026
Q2
$876 Buy
+13
New +$866 ﹤0.01% 507
2026
Q1
– Sell
-3
Closed -$199 – 606
2025
Q4
$199 Buy
+3
New +$194 ﹤0.01% 561

Other funds holding DXCM

Davis Capital Management's DXCM Position: Q3 2026 in Review

Davis Capital Management held its DexCom (DXCM) position steady in Q3 2026 at 13 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Davis Capital Management first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 924 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Davis Capital Management held 13 shares of DexCom worth $1.12K as of Q3 2026.
  • Davis Capital Management left its DexCom share count unchanged in Q3 2026.
  • DexCom made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #490 holding.
  • Davis Capital Management first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 924 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.